I wrote yesterday about Xbrane. Most interesting biotech play in Scandinavia. Phase 3 study just completed. The company announced an Investor day in four weeks time. Clear indication of positive outcome. Analysts believe the share price will double this year and double again next year. Very bullish.
Today a good article was published on SeekingAlpha. Worth the read:
SIGN UP TO RECEIVE THE POSTS BY EMAIL